KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $6.3 billion.

  • Eli Lilly's Other Non-Current Liabilities rose 6225.64% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 6225.64%. This contributed to the annual value of $4.1 billion for FY2024, which is 549.98% up from last year.
  • As of Q3 2025, Eli Lilly's Other Non-Current Liabilities stood at $6.3 billion, which was up 6225.64% from $5.7 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Other Non-Current Liabilities registered a high of $6.3 billion during Q3 2025, and its lowest value of $3.3 billion during Q2 2023.
  • For the 5-year period, Eli Lilly's Other Non-Current Liabilities averaged around $4.1 billion, with its median value being $3.8 billion (2023).
  • As far as peak fluctuations go, Eli Lilly's Other Non-Current Liabilities crashed by 637.79% in 2023, and later skyrocketed by 6256.65% in 2025.
  • Over the past 5 years, Eli Lilly's Other Non-Current Liabilities (Quarter) stood at $3.9 billion in 2021, then decreased by 5.37% to $3.7 billion in 2022, then increased by 3.76% to $3.8 billion in 2023, then increased by 5.5% to $4.1 billion in 2024, then surged by 54.98% to $6.3 billion in 2025.
  • Its Other Non-Current Liabilities stands at $6.3 billion for Q3 2025, versus $5.7 billion for Q2 2025 and $5.4 billion for Q1 2025.